Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany.
Haemophilia. 2009 Sep;15(5):1143-53. doi: 10.1111/j.1365-2516.2009.02048.x. Epub 2009 May 26.
Coagulation factor V (FV) plays an important role in the blood coagulation cascade as part of the prothrombinase complex. FV deficiency is a rare autosomal recessive bleeding disorder with variable phenotypic expression. Thus, our study reports 39 patients with FV deficiency. In 36 cases, we were able to identify a causative mutation. Of these, 20 patients were heterozygous for the identified mutation, nine were homozygous, six were compound heterozygous and one proband was pseudohomozygous. In the remaining patients, no mutation was found. A total of 42 genetic alterations (of which 33 were uniquely different mutations), comprising 19 missense mutations, eight nonsense mutations, four small deletions and two splice site mutations, were identified by this study. Twenty-three of these were novel sequence variations not previously described in the literature. Interestingly, all changes found in exon 13 resulted in null alleles as either nonsense mutations or small deletions. The overall profile of these new mutations corresponds well with the data published in the F5 database. In those cases, where data were available, information on FV activity levels and/or bleeding history is given. Interestingly, some patients with mild FV deficiency (FV:C about 50% of normal) also exhibited bleeding episodes. Our data substantially contribute to the broadening and better understanding of the FV deficiency mutational spectrum. Identifying the molecular basis of mutations underlying this rare coagulation disorder will allow more insight into the mechanisms involved in the variable clinical phenotypes of patients with FV deficiency.
凝血因子 V(FV)作为凝血酶原酶复合物的一部分,在血液凝固级联反应中起着重要作用。FV 缺乏症是一种罕见的常染色体隐性出血性疾病,具有不同的表型表达。因此,我们的研究报告了 39 例 FV 缺乏症患者。在 36 例中,我们能够确定一个致病突变。其中,20 例为鉴定突变的杂合子,9 例为纯合子,6 例为复合杂合子,1 例先证者为假纯合子。在其余患者中,未发现突变。通过本研究共鉴定出 42 种遗传改变(其中 33 种为独特的不同突变),包括 19 种错义突变、8 种无义突变、4 种小缺失和 2 种剪接位点突变。其中 23 种为以前文献中未描述的新序列变异。有趣的是,在外显子 13 中发现的所有变化均导致无义突变或小缺失,从而导致无效等位基因。这些新突变的总体特征与在 F5 数据库中发表的数据非常吻合。在有数据的情况下,给出了 FV 活性水平和/或出血史的信息。有趣的是,一些 FV 缺乏症(FV:C 约为正常的 50%)轻度患者也有出血发作。我们的数据大大有助于拓宽和更好地了解 FV 缺乏症的突变谱。确定导致这种罕见凝血障碍的突变的分子基础将使我们更深入地了解 FV 缺乏症患者不同临床表现的机制。